DNA-PK hyperactivation occurs in deletion 11q chronic lymphocytic leukemia and is both a biomarker and therapeutic target for drug-resistant disease.
作者信息
Kost Sara E F, Saleh Ali, Yuan Shek H, Kuzio Bozena, Gibson Spencer B, Yang Lin, Banerji Versha, Johnston James B, Katyal Sachin
机构信息
CancerCare Manitoba Research Institute, CancerCare Manitoba, Winnipeg, MB, R3E 0V9, Canada.
Department of Pharmacology and Therapeutics, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, R3E 3P4, Canada.
出版信息
Blood Cancer J. 2023 Jan 27;13(1):20. doi: 10.1038/s41408-022-00781-8.
Abstract
摘要
Zotero 插件